These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 27367008

  • 21. Association of overexpression of efflux pump genes with antibiotic resistance in Pseudomonas aeruginosa strains clinically isolated from urinary tract infection patients.
    Shigemura K, Osawa K, Kato A, Tokimatsu I, Arakawa S, Shirakawa T, Fujisawa M.
    J Antibiot (Tokyo); 2015 Sep; 68(9):568-72. PubMed ID: 25850341
    [Abstract] [Full Text] [Related]

  • 22. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
    Najar Peerayeh S, Pirhajati Mahabadi R, Pakbaten Toupkanlou S, Siadat SD.
    Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
    [Abstract] [Full Text] [Related]

  • 23. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients.
    Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N.
    Burns; 2010 Feb; 36(1):70-4. PubMed ID: 19524369
    [Abstract] [Full Text] [Related]

  • 24. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A, GERPA Study Group.
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [Abstract] [Full Text] [Related]

  • 25. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran.
    Khosravi AD, Mihani F.
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):125-8. PubMed ID: 17900848
    [Abstract] [Full Text] [Related]

  • 26. Association of carbapenem and multidrug resistance with the expression of efflux pump-encoding genes in Pseudomonas aeruginosa clinical isolates.
    Yousefi S, Nazari M, Ramazanzadeh R, Sahebkar A, Safarzadeh E, Khademi F.
    Acta Microbiol Immunol Hung; 2023 Jun 16; 70(2):161-166. PubMed ID: 37227802
    [Abstract] [Full Text] [Related]

  • 27. Phenotypic and genotypic assessment of fluoroquinolones and aminoglycosides resistances in Pseudomonas aeruginosa collected from Minia hospitals, Egypt during COVID-19 pandemic.
    Boushra MR, Gad GFM, Hassuna NA, Waly NGF, Ibrahem RA.
    BMC Infect Dis; 2024 Jul 31; 24(1):763. PubMed ID: 39085804
    [Abstract] [Full Text] [Related]

  • 28. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT, Tessier PR, Li C, Nightingale CH, Nicolau DP.
    Diagn Microbiol Infect Dis; 2007 Feb 31; 57(2):153-61. PubMed ID: 16930925
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland.
    Michalska AD, Sacha PT, Ojdana D, Wieczorek A, Tryniszewska E.
    Braz J Microbiol; 2014 Feb 31; 45(4):1455-8. PubMed ID: 25763054
    [Abstract] [Full Text] [Related]

  • 30. Detection of metallo-β-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran.
    Yousefi S, Farajnia S, Nahaei MR, Akhi MT, Ghotaslou R, Soroush MH, Naghili B, Jazani NH.
    Diagn Microbiol Infect Dis; 2010 Nov 31; 68(3):322-5. PubMed ID: 20846807
    [Abstract] [Full Text] [Related]

  • 31. Prevalence and mechanisms of aminoglycoside resistance among drug-resistant Pseudomonas aeruginosa clinical isolates in Iran.
    Saeli N, Jafari-Ramedani S, Ramazanzadeh R, Nazari M, Sahebkar A, Khademi F.
    BMC Infect Dis; 2024 Jul 09; 24(1):680. PubMed ID: 38982386
    [Abstract] [Full Text] [Related]

  • 32. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A, Eroğlu C, Esen S, Sünbül M, Leblebicioğlu H.
    Mikrobiyol Bul; 2012 Jan 09; 46(1):1-8. PubMed ID: 22399165
    [Abstract] [Full Text] [Related]

  • 33. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
    Chuanchuen R, Wannaprasat W, Ajariyakhajorn K, Schweizer HP.
    Microbiol Immunol; 2008 Aug 09; 52(8):392-8. PubMed ID: 18667038
    [Abstract] [Full Text] [Related]

  • 34. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
    Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O, Marty N, Grattard F, Mariani-Kurkdjian P, Bingen E, Husson MO, Couetdic G, Plésiat P.
    Antimicrob Agents Chemother; 2007 Oct 09; 51(10):3531-6. PubMed ID: 17682106
    [Abstract] [Full Text] [Related]

  • 35. Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains.
    Zahedi Bialvaei A, Rahbar M, Hamidi-Farahani R, Asgari A, Esmailkhani A, Mardani Dashti Y, Soleiman-Meigooni S.
    Microb Pathog; 2021 Apr 09; 153():104789. PubMed ID: 33556480
    [Abstract] [Full Text] [Related]

  • 36. A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates.
    Coban AY, Ekinci B, Durupinar B.
    Chemotherapy; 2004 Apr 09; 50(1):22-6. PubMed ID: 15084801
    [Abstract] [Full Text] [Related]

  • 37. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C.
    J Antimicrob Chemother; 2008 Aug 09; 62(2):316-23. PubMed ID: 18467306
    [Abstract] [Full Text] [Related]

  • 38. Role of efflux pumps inhibitor in decreasing antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in North India.
    Filgona J, Banerjee T, Anupurba S.
    J Infect Dev Ctries; 2015 Aug 29; 9(8):815-20. PubMed ID: 26322872
    [Abstract] [Full Text] [Related]

  • 39. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.
    Muller C, Plésiat P, Jeannot K.
    Antimicrob Agents Chemother; 2011 Mar 29; 55(3):1211-21. PubMed ID: 21149619
    [Abstract] [Full Text] [Related]

  • 40. Coexistence of multidrug resistance mechanisms and virulence genes in carbapenem-resistant Pseudomonas aeruginosa strains from a tertiary care hospital in South India.
    Ellappan K, Belgode Narasimha H, Kumar S.
    J Glob Antimicrob Resist; 2018 Mar 29; 12():37-43. PubMed ID: 28893647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.